Charles River Laboratories International Stock News

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call

Charles River (CRL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Charles River (CRAI) welcomes Elizabeth Bailey to the position of vice president of its Antitrust & Competition Economics Practice in Oakland.

Charles River (CRL) announced a retirement and transition plan for its CFO.David R

Charles River (CRAI) welcomes Peggy Daley to the position of vice president its Energy Practice.

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CRL--Charles River Laboratories to present at J.P. Morgan Healthcare Conference

Charles River (CRAI) rides on its strong global presence, business diversification and an excellent professional team.

DUBLIN--(BUSINESS WIRE)--The "Knock out Mouse Model Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com''s offering. The Knock Out Mouse Model Market Size is projected to register a CAGR of 5.2% during the forecast period. Companies Mentioned Charles River Laboratories International Inc. Cyagen Biosciences. Envigo genOway Ozgene Pty Ltd. Taconic Biosciences, Inc. THE JACKSON LABORATORY TRANS GENIC INC. Key Market Trends Constitut

Charles River Laboratories International (NYSE:CRL) and iSpecimen (NASDAQ:ISPC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, analyst recommendations, earnings and dividends. Analyst Recommendations This is a summary of recent ratings and recommmendations for Charles River Laboratories []

Wall Street brokerages forecast that Charles River Laboratories International, Inc. (NYSE:CRL) will post sales of $891.50 million for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for Charles River Laboratories Internationals earnings, with the lowest sales estimate coming in at $875.12 million and the highest estimate coming in at $921.78 million. []

Whittier Trust Co. of Nevada Inc. boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL) by 4.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,335 shares of the medical research companys stock after purchasing an additional 235 shares during []

Bank of America Corp DE boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 14.7% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 603,466 shares of the medical research companys stock after buying an additional 77,146 shares during the quarter. []

Investors are optimistic about Charles River (CRL) on acquisitions of Cognate BioServices and Vigene Biosciences.

New Jersey, United States,- Verified Market Research has recently published a research report titled, Veterinary CRO Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. Primary and secondary research methodologies have been used to formulate